as 04-24-2025 4:00pm EST
Founded: | 1994 | Country: | United States |
Employees: | N/A | City: | WIXOM |
Market Cap: | N/A | IPO Year: | 1998 |
Target Price: | $4.00 | AVG Volume (30 days): | 223.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.03 | EPS Growth: | N/A |
52 Week Low/High: | $0.86 - $5.15 | Next Earning Date: | 05-12-2025 |
Revenue: | $101,489,000 | Revenue Growth: | 21.38% |
Revenue Growth (this year): | -32.24% | Revenue Growth (next year): | 10.42% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Irrevocable Larson Family Investment Trust | RMTI | 10% Owner | Apr 10 '25 | Buy | $1.07 | 87,500 | $94,017.70 | 3,557,500 | |
Neri Jesse | RMTI | SVP, FINANCE AND CFO | Apr 1 '25 | Sell | $1.10 | 886 | $974.60 | 30,000 | |
Strobeck Mark | RMTI | President and CEO | Apr 1 '25 | Sell | $1.08 | 6,926 | $7,480.08 | 124,678 | |
Chole Timothy | RMTI | SVP, Chief Commercial Officer | Apr 1 '25 | Sell | $1.08 | 2,868 | $3,097.44 | 46,035 |
RMTI Breaking Stock News: Dive into RMTI Ticker-Specific Updates for Smart Investing
Argus Research
9 days ago
Business Wire
11 days ago
Insider Monkey
a month ago
Simply Wall St.
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
Thomson Reuters StreetEvents
a month ago
Zacks
a month ago
The information presented on this page, "RMTI Rockwell Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.